ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

Recruiting now

Conditions studied: Acute Hepatic Porphyria

In brief

This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effectiveness of givosiran and other approved AHP therapies.

Key facts

Study ID
NCT04883905
Run by
Alnylam Pharmaceuticals
People needed
150
Starts
2021-04-26
Expected to finish
2027-04-01
Last updated by the study team
2026-04-27

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.